Publié le 01.05.2019 08:36
The following paper was accepted for publication:
We had communications at the 21st Annual European Pharma Congress. May 20-22, 2019, Zürich, Switzerland:
Ferritin-antibody fragment conjugates: protein scaffolds to modify physicochemical and pharmacokinetic properties of biotherapeutics.
W. Shatz, C. Blanchette, R. F. Kelley, R. Perozzo, Y. N. Kalia
and the 21st Transporter and Barrier Meeting. May 27-29, 2019, Bad Herrenalb, Karlsruhe, Germany:
Investigation of apical drug transporter activity using ex vivo porcine intestine to facilitate identification of potential drug-drug-interactions at an early state of drug development.
Y. E. Arnold, Y. N. Kalia